Home/Filings/4/0001235802-20-000045
4//SEC Filing

Morton Andrew C. 4

Accession 0001235802-20-000045

CIK 0001492658other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:15 PM ET

Size

5.4 KB

Accession

0001235802-20-000045

Insider Transaction Report

Form 4
Period: 2020-05-18
Morton Andrew C.
SVP Chief Human Resources Ofr
Transactions
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2020-05-18$29.79/sh2,284$68,04024,651 total
Footnotes (2)
  • [F1]These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes 11,354 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 6,401 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001498511

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:15 PM ET
Size
5.4 KB